Bland S Karlyn, Clark Mary Ellen, Côté Olivier, Bienzle Dorothee
Department of Pathobiology, University of Guelph, Guelph, ON, Canada.
BioAssay Works, Ijamsville, MD, USA.
J Feline Med Surg. 2019 Dec;21(12):1069-1079. doi: 10.1177/1098612X18812494. Epub 2018 Nov 21.
The aim of this study was to design and carry out a preliminary evaluation of a urine point-of-care test for kidney injury molecule 1 (KIM-1) in healthy and diseased cats.
Part of the feline gene was amplified, ligated into a plasmid with a signal peptide and monomeric human IgGFc, and transfected into a mammalian cell line. Supernatant was purified and tested for the fusion protein by gel electrophoresis and Western blot. Mice were immunized three times with purified proteins, and hybridomas were generated from splenocytes. Antibodies were tested by ELISA for detection of recombinant KIM-1 and naturally occurring KIM-1 in disease-state urine. Next, a lateral flow assay (LFA) with capture and detection antibodies was constructed, and tested with 34 urine samples from healthy and diseased cats. Antibodies were also tested for reactivity with formalin-fixed paraffin-embedded kidney tissue.
Three antibodies were assessed. Antibodies detected between 0.4 and 60 ng/ml feline KIM-1 fusion protein in the LFA. Urine samples from healthy cats yielded faint bands in the LFA corresponding to optical density (OD) values of 4.8-8.8. Samples from cats with suspected or confirmed acute kidney injury (AKI) had OD values ranging from 1.6-20.5. Urine KIM-1 varied over multiple days in cats with sepsis or urethral obstruction despite normalizing serum creatinine concentration. In tissue sections, KIM-1 antibodies labeled tubular cells with morphological features of injury.
A practical patient-side assay for detection of KIM-1 in feline urine has been developed. Preliminary results show marked though transient increases in cats with sepsis and urethral obstruction-associated AKI, and expression in injured tubules. Although initial data indicating that the LFA is sensitive and specific for KIM-1 in cats with AKI are promising, values associated with different types of injury, urine collection, urine storage and specific gravity need to be investigated.
本研究旨在设计并开展一项针对健康和患病猫的肾损伤分子1(KIM-1)尿液即时检测的初步评估。
扩增猫基因的一部分,将其连接到带有信号肽和单体人IgGFc的质粒中,并转染到哺乳动物细胞系中。对上清液进行纯化,并通过凝胶电泳和蛋白质印迹法检测融合蛋白。用纯化蛋白对小鼠进行三次免疫,从脾细胞中产生杂交瘤。通过酶联免疫吸附测定法检测抗体,以检测疾病状态尿液中的重组KIM-1和天然存在的KIM-1。接下来,构建了一种带有捕获抗体和检测抗体的侧向流动分析(LFA),并用来自健康和患病猫的34份尿液样本进行测试。还检测了抗体与福尔马林固定石蜡包埋肾组织的反应性。
评估了三种抗体。这些抗体在LFA中检测到0.4至60 ng/ml的猫KIM-1融合蛋白。健康猫的尿液样本在LFA中产生微弱条带,对应光密度(OD)值为4.8 - 8.8。疑似或确诊为急性肾损伤(AKI)的猫的样本OD值范围为1.6 - 20.5。尽管血清肌酐浓度恢复正常,但患有败血症或尿道梗阻的猫尿液KIM-1在数天内有所变化。在组织切片中,KIM-1抗体标记具有损伤形态特征的肾小管细胞。
已开发出一种用于检测猫尿液中KIM-1的实用床边检测方法。初步结果显示,患有败血症和尿道梗阻相关AKI的猫中KIM-1有显著但短暂的升高,且在受损肾小管中有表达。尽管初步数据表明LFA对患有AKI的猫的KIM-1敏感且特异,但与不同类型损伤、尿液收集、尿液储存和比重相关的值仍需研究。